» Articles » PMID: 3918340

Kinetic Evaluation of Four Factor VIII Concentrates by Model-independent Methods

Overview
Specialty Hematology
Date 1985 Jan 1
PMID 3918340
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Single-dose kinetics of 4 Factor VIII concentrates (Kryobulin, Hemofil T, Koate, cryoprecipitate) were studied in 41 patients with haemophilia-A. Model-independent methods were adopted for calculating the kinetic parameters (area under the curve, clearance, area under the moment curve, mean residence time, volume of distribution at steady-state). No substantial difference was observed in the kinetic characteristics of the 4 Factor VIII concentrates. A considerable interindividual variability of the calculated kinetic parameters was demonstrated for all concentrates. Our findings support the need to individualize Factor VIII dosage.

Citing Articles

Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life.

Morfini M, Peyvandi F, Mancuso M, Marchesini E, Tagliaferri A, Gualtierotti R J Clin Med. 2024; 13(17).

PMID: 39274196 PMC: 11396525. DOI: 10.3390/jcm13174986.


A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects.

Blanchette V, Zunino L, Grassmann V, Barnes C, Carcao M, Curtin J Thromb Haemost. 2021; 121(10):1326-1336.

PMID: 33506480 PMC: 8494515. DOI: 10.1055/a-1376-0970.


Analysis of Survival Curves: Statistical Methods Accounting for the Presence of Long-Term Survivors.

Damuzzo V, Agnoletto L, Leonardi L, Chiumente M, Mengato D, Messori A Front Oncol. 2019; 9:453.

PMID: 31231609 PMC: 6558210. DOI: 10.3389/fonc.2019.00453.


The History of Clotting Factor Concentrates Pharmacokinetics.

Morfini M J Clin Med. 2017; 6(3).

PMID: 28335525 PMC: 5373004. DOI: 10.3390/jcm6030035.


Pediatric Dosing and Body Size in Biotherapeutics.

Shi R, Derendorf H Pharmaceutics. 2016; 2(4):389-418.

PMID: 27721364 PMC: 3967145. DOI: 10.3390/pharmaceutics2040389.